How soon can a new brand be launched from scratch?
Каждый проект всегда индивидуален, поэтому мы можем назвать только ориентировочные сроки. Запустить на рынок новый бренд БАД довольно быстро. Если продукт выбирается из списка наших готовых и зарегистрированных рецептур, от заказчика требуется только согласование дизайна и заказа упаковочных материалов. Такие заказы исполняются в срок до 2-3 месяцев. Если планируется новый состав, потребуется его научная и […]
Every project is unique, so we can only provide estimated timelines.
Launching a new dietary supplement brand on the market is quite quick. If the product is selected from our list of ready‑made and registered formulations, the customer only needs to approve the design and place an order for packaging materials. Such orders are completed within 2–3 months.
If a new composition is planned, its scientific and technological development will be required, as well as the state registration procedure. Such projects are usually implemented within a period of up to 6 months.
Launching a new pharmaceutical will take much longer than launching a dietary supplement. It can take 5–10 years from the emergence of the idea for a new drug to its launch on the market: full pharmaceutical development of the formula, preclinical studies to test the hypothesis and confirm the mechanism of action; then phase I and phase II clinical trials involving volunteers for a comprehensive assessment of safety and efficacy. Only after that is it possible to register the medicinal product, which is accompanied by mandatory confirmation of the quality control of the production process.
Launching a generic drug is simpler and faster, potentially taking about a year and a half. Since the pharmaceutical development phase and in-depth research have already been completed for the original drug, a generic version does not require extensive clinical or preclinical studies. Typically, a bioequivalence study is sufficient; in other words, it is necessary to demonstrate that the formulation matches that of the original (reference) drug.